MarginsXMarginsX
Home › Markets › Health Care › SGP

SpyGlass Pharma Inc. (SGP)

SGP trades on Nasdaq in Health Care, Medical/Dental Instruments. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$32.24
-1.95% on the day
Market cap
$1.1B
Small cap
Revenue
Recent IPO: no annual report filed yet
Net income
Recent IPO: no annual report filed yet

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026.

Profile

FieldValue
TickerSGP on Nasdaq
SectorHealth Care
IndustryMedical/Dental Instruments
CountryUnited States
IPO year2026
SEC CIK0001778922

Financials

Recent IPO: no annual report filed yet.

Warning signs

Cash runway
46.6 months
$208.7M cash at September 30, 2026
Share count, 1 year
No year-earlier count
Going-concern doubt
No
10-Q filed November 12, 2026
Insider net buying, 12 months
$83.8M
Through September 30, 2026
SignFindingSource
Going concernNo going-concern finding.10-Q 2026-11-12
Cash and burn$208.7M cash; operating cash flow -$13.4M a quarter.Report 2026-09-30
Shares outstanding33,461,450 (2026-11-02).Cover page 2026-11-02
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 0 424B5 takedownsNone on EDGAR
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorDeloitte & Touche LLP, Costa Mesa, California, United StatesPCAOB Form AP 2026-04-15
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $83.8M, sold $0 on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q3 2026
2026-09-30
Not filed-$24.3M-$16.0M$208.7MNo debt tagsNeeds four quarters10-Q 2026-11-12
Q2 2026
2026-06-30
Not filed-$19.9M-$14.8M$223.1MNo debt tagsNeeds four quarters10-Q 2026-11-12
Q1 2026
2026-03-31
Not filed-$13.8M-$13.5M$238.9MNo debt tagsNeeds four quarters10-Q 2026-11-12
Q4 2025
2025-12-31
Not filed-$12.6M-$9.3M$96.4MNo debt tagsNeeds four quarters10-K 2026-03-26
Q3 2025
2025-09-30
Not filed-$9.8M-$8.8M$106.0MNo debt tagsNeeds four quarters10-Q 2026-11-12
Q2 2025
2025-06-30
Not filed-$8.7M-$6.3M$127.2MNo debt tagsNeeds four quarters10-Q 2026-11-12
Q1 2025
2025-03-31
Not filed-$8.8M-$8.2M$58.0MNo debt tagsNeeds four quarters10-Q 2026-11-12

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

The SEC filing list did not load in time for this page. It is on SEC EDGAR and in the full dossier.

Price moves

WindowReturn
1 week-11.0%
1 month+37.5%
3 months+30.6%
Year to dateNot enough price history
1 yearNot enough price history
From 52-week high-14.3%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Medical/Dental Instruments

TickerCompanyPriceDayMarket cap
IRMDiRadimed Corporation$84.84-0.60%$1.1B
IARTIntegra LifeSciences Holdings Corporation$13.98-2.92%$1.1B
SIBNSI-BONE Inc.$23.41-0.13%$1.1B
ATECAlphatec Holdings Inc.$6.78-4.10%$1.1B
DRTSAlpha Tau Medical Ltd.$11.97-10.54%$1.1B
TNDMTandem Diabetes Care Inc.$18.48-7.92%$1.3B
AORTArtivion Inc.$18.47-3.30%$901.1M
BVSBioventus Inc.$10.46-1.88%$881.4M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier